Using Stem Cell-Derived Organoids to Manage Parkinson’s Disease

At the University of Luxembourg, Professor Jens Christian Schwamborn and his team are developing brain organoids derived from patient-specific stem cells to create more relevant disease models for Parkinson’s and other neurological disorders.